NRX Pharmaceuticals, Inc. (NRXP) Capital expenditures 2020–2024
NRX Pharmaceuticals, Inc. (NRXP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2024 · since FY2020: $2,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $3,000 | -70.0% |
| FY2022 | $10,000 | +42.9% |
| FY2021 | $7,000 | +250.0% |
| FY2020 | $2,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice